Health Catalyst (NASDAQ:HCAT) Cut to Neutral at BTIG Research
BTIG Research downgraded shares of Health Catalyst (NASDAQ:HCAT – Free Report) from a buy rating to a neutral rating in a research note released on Tuesday, MarketBeat.com reports. Other analysts have also recently issued research reports about the company. Canaccord Genuity Group lowered their price target on Health Catalyst from $10.00 to $9.00 and set […]
BTIG Research downgraded shares of Health Catalyst (NASDAQ:HCAT – Free Report) from a buy rating to a neutral rating in a research note released on Tuesday, MarketBeat.com reports. Other analysts have also recently issued research reports about the company. Canaccord Genuity Group lowered their price target on Health Catalyst from $10.00 to $9.00 and set […]
